Clinical Trial Update: Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on tolerogenic dendritic cell therapy for rheumatoid arthritis spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tolerogenic Dendritic Cell Therapy

Snippet

Sponsor: UMC Utrecht | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: UNKNOWN